Announced Thu, 14 May · 08:29 IST

The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gaurang Thakker

Promoter Stake BuyOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.4%1-day move

₹185.80

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-0.4-1.8-0.4-0.4-2.0-3.4+23.6+14.0+32.9—

Up moveDown movePending

AI summary

Promoter Gaurang Rameshchandra Thakker acquired 18,000 equity shares (0.26%) of Aptus Pharma Limited on 11 May 2026 through open market. Before the acquisition, he held 5,75,000 shares (8.38%). After the acquisition, his holding increased to 5,93,000 shares (8.64%) out of total 68,60,000 equity shares. The mode of acquisition is listed as NA (off-market/inter-se transfer among Promoter Group). This is a disclosure under SEBI SAST Regulations requiring disclosure when a promoter acquires shares beyond certain thresholds.

Likely market impact

This is a minor promoter stake increase of 0.26%. While it signals confidence in the company, the absolute holding remains modest at 8.64%, and no takeover threshold is currently threatened.